[The effect of benzohexonium on myocardial metabolic processes in the presence of neurogenic heart pathology].
D000818:Animals; D001011:Aorta / Q000502:physiology; D004558:Electric Stimulation; D004562:Electrocardiography; D004734:Energy Metabolism / Q000187:drug effects*; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000294:innervation*; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D007773:Lactates / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D011817:Rabbits; D012018:Reflex / Q000187:drug effects
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D007773:Lactates; D010725:Phosphocreatine; D009638:Norepinephrine
Vliianie benzogeksoniia na obmennye protsessy miokarda pri neĭrogennoĭ patologii serdtsa